Medicalgorithmics signs agreement with Samsung spinoff
The Warsaw Stock Exchange-listed Polish medtech company, Medicalgorithmics, has signed an agreement with leading Korean distributor Wellysis – a spinoff of Samsung specializing in ECG monitoring, predictive analytics, and artificial intelligence models in healthcare. Under the agreement, the innovative DeepRhythm Platform (DRP) and DeepRhythmAI (DRAI) algorithms will be integrated with Wellysis’s flagship device, the FDA-approved S-Patch, and will be made available to all current and future customers of both companies, including those in the United States. This marks the eleventh agreement signed by Medicalgorithmics this year.